Quality use of medicines: The postmenopausal woman with osteoporosis
Guidelines for the management of any condition suffer the ravages of time and can be challenged even by the publication of a single study. This may well apply to any guidelines that include hormone replacement therapy (HRT), such as the Osteoporosis Clinical Guideline published in 2000 by the South...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2003-05-01
|
| Series: | South African Family Practice |
| Subjects: | |
| Online Access: | https://safpj.co.za/index.php/safpj/article/view/1944 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Guidelines for the management of any condition suffer the ravages of time and can be challenged even by the publication of a single study. This may well apply to any guidelines that include hormone replacement therapy (HRT), such as the Osteoporosis Clinical Guideline published in 2000 by the South African Medical Association. Nothing that 'reliable comparative data on the various drugs registered for the treatment of osteoporosis are not available', the Osteoporosis Working Group attempted to guide clinicians' drug choices. |
|---|---|
| ISSN: | 2078-6190 2078-6204 |